REXAM PLC is on course to replicate its 2011 financial performance despite the volatile economic climate.
Results for the group are in line with expectations with volumes in its European business driven by good growth in Western Europe and speciality cans partly offset by Russia where it experienced a strong performance in the first quarter of last year.
Its healthcare business is trading as expected, slightly below the equivalent period in 2011 primarily as a result of a product coming off patent and a weak flu season.
Chief executive Graham Chipchase said: “The global economic outlook remains uncertain but, at this stage, we continue to expect 2012 to be another year of progress.”
